ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1145

The Prostate Plays a Role in Serum Urate Levels and the Risk of Gout in Men

Mariana Urquiaga1, Megan Leask1, Nicholas Sumpter1, Brooke Maxwell2, Sara Lewis2, Eric E. Kelley2 and Tony Merriman3, 1University of Alabama at Birmingham, Birmingham, AL, 2West Virginia University, Morgantown, WV, 3University of Otago, Dunedin, New Zealand

Meeting: ACR Convergence 2022

Keywords: Crystal-induced arthritis, Genomics and Proteomics

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Genetics, Genomics and Proteomics Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Men have higher serum urate (SU) and increased prevalence of gout compared to pre-menopausal women. Xanthine oxidoreductase (XOR), encoded by the XDH gene, is the sole enzyme responsible for urate production in mammals. In a gout GWAS study (Abstract ID 1288189) we identified a genetic association at the XDH locus with gout that co-localized with a genetic signal of control of XDH expression that is specific to the prostate. This finding has generated the novel hypothesis that the prostate plays a role in urate homeostasis and the risk of gout in men. This hypothesis is supported by evidence that urate is a constituent of semen1,2 and the presence of urate crystals in non-malignant prostate sections3. Here we tested for the expression of XDH and urate transporters in the human prostate and for XOR activity and uric acid in the murine prostate.

Methods: We used publicly-available single cell RNA sequencing data4 to evaluate the expression of XDH and urate transporters in specific cell types in the prostate. We measured uric acid concentration and XOR activity from the prostate of 7-week C57Bl/J6 mice.

Results: XDH is expressed in prostatic basal and urothelial cells (Figure 1). The major urate transporter genes ABCG2, SLC2A9, and ABCC4 (encoding ABCG2, GLUT9, and MRP4 respectively) were expressed in different prostate cell types (Figure 1), however expression of other urate transporters was negligible (data not shown). XDH and SLC2A9 had overlapping expression patterns in the basal and urothelial cells of the prostate. The secretory transporter ABCC4 was ubiquitously expressed, although predominantly in glandular cells. The expression of the secretory transporter ABCG2 was at a high level restricted to endothelial cells. In mice, XOR activity was higher in the liver than the prostate, however concentration of uric acid (per mg protein) was higher in the prostate (Figure 2).

Conclusion: XDH is expressed in the human prostate. In the mouse prostate, XOR is active and uric acid is synthesized. The presence of XDH and urate transporters in the prostate, provides a potential mechanism for prostatic production and secretion of urate into the blood. Production by XOR and transport of urate by GLUT9 in epithelial cells, combined with transport into the blood by ABCG2 is a testable model. Together, these results further support the hypothesis that the prostate may play a role in the increased urate levels and risk of gout in men.

Supporting image 1

Cell-specific expression of XDH and urate transporters in the prostate. (Image credit: Human Protein Atlas, image available from v21.1.proteinatlas.org)

Supporting image 2

Tissue XOR activity and urate levels in the liver, prostate, and seminal vesicles of male mice


Disclosures: M. Urquiaga, None; M. Leask, None; N. Sumpter, None; B. Maxwell, None; S. Lewis, None; E. Kelley, None; T. Merriman, None.

To cite this abstract in AMA style:

Urquiaga M, Leask M, Sumpter N, Maxwell B, Lewis S, Kelley E, Merriman T. The Prostate Plays a Role in Serum Urate Levels and the Risk of Gout in Men [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/the-prostate-plays-a-role-in-serum-urate-levels-and-the-risk-of-gout-in-men/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-prostate-plays-a-role-in-serum-urate-levels-and-the-risk-of-gout-in-men/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology